Presentation Type: Oral
0013 Pre-operative prediction of margin requirement following a core biopsy suggestive of a phyllodes tumour.
Valentine Mberu1, E. Jane Macaskill2, Colin Purdie2, Andrew Evans1
1University of Dundee, Dundee, United Kingdom; 2Ninewells Hospital, NHS Tayside, Dundee, United Kingdom
Correspondence: Valentine Mberu
0015 Data from 11.3 million screens in the NHSBSP. Is there an inverse relationship between grade and mammographic sensitivity?
Rosalind Given-Wilson1, Matthew Wallis2, Roger Blanks3
1St Georges Hospital, London, United Kingdom; 2Addenbrookes Hospital, Cambridge, United Kingdom; 3Oxford University, Oxford, United Kingdom
Correspondence: Rosalind Given-Wilson
0025 Comparison of margin visibility for masses on digital breast tomosynthesis (DBT) and 2D digital mammography (2DMM); can it help reduce recall and benign biopsy rate in the screening setting?
Nyla Khan, Linda Metaxa, Tamara Suaris
St Bartholomew's Hospital, Barts and The Royal London NHS Trust, London, United Kingdom
Correspondence: Nyla Khan
0070 Radio-wave image guided biopsy needle for breast diagnostic
Louis Tsui1, Peter Brady2, Mark Beaumont1
1Micrima Ltd, Bristol, United Kingdom; 2Covensis, Farndon, United Kingdom
Correspondence: Louis Tsui
0074 Can real-life screening performance be predicted by an individual’s PERFORMS data?
Yan Chen1, Jonathan James2, Eleanor Cornford3, Jacquie Jenkins4
1University of Nottingham, Nottingham, United Kingdom; 2Nottingham Breast Institute, Nottingham, United Kingdom; 3Gloucestershire Hospitals NHS Foundation Trust, Cheltham, United Kingdom; 4Public Health England, Sheffield, United Kingdom
Correspondence: Yan Chen
0096 Masking Risk Index: an evaluation to guide supplemental imaging for breast screening.
Sarah Hickman, Maria Pantelidou, James Mainprize, Martin Yaffe, Yuan Huang, Richard Black, Fiona Gilbert
University of Cambridge, Cambridge, United Kingdom 2Sunnybrook Research Institute , Toronto , Canada
Correspondence: Sarah Hickman
0089 Breast Cancer: Early diagnosis using materials immortalisation
Keith Rogers1, Iain Lyburn2, Sarah Gosling1, Nicholas Stone3, Nallala Krupakar3
1Cranfield University, Swindon, United Kingdom 2Cobalt Health, Cheltenham, United Kingdom 3Exeter University, Exeter, United Kingdom
Correspondence: Keith Rogers
Presentation Type: Poster
0014 NHS Breast Screening Programme - Can we safely reduce our clinical recall rate?
Jennifer Birtchnell, Gillian Hutchison
The Nightingale Centre, Manchester, United Kingdom
Correspondence: Jennifer Birtchnell
Identifying the number of women clinically recalled to assessment over a 3-year round length
Ascertaining the reason for clinical recall and result of assessment.
Identifying the cancer detection rate in this population.